Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLOV logo CLOV
Upturn stock ratingUpturn stock rating
CLOV logo

Clover Health Investments Corp (CLOV)

Upturn stock ratingUpturn stock rating
$3.36
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

03/11/2025: CLOV (5-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 116.8%
Avg. Invested days 32
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 03/11/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.72B USD
Price to earnings Ratio -
1Y Target Price 4.75
Price to earnings Ratio -
1Y Target Price 4.75
Volume (30-day avg) 5938407
Beta 2.01
52 Weeks Range 0.61 - 4.87
Updated Date 03/11/2025
52 Weeks Range 0.61 - 4.87
Updated Date 03/11/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.09

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-03-10
When Before Market
Estimate -0.065
Actual -0.05

Profitability

Profit Margin -3.14%
Operating Margin (TTM) -6.37%

Management Effectiveness

Return on Assets (TTM) -4.99%
Return on Equity (TTM) -14.75%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 1389815072
Price to Sales(TTM) 1.25
Enterprise Value 1389815072
Price to Sales(TTM) 1.25
Enterprise Value to Revenue 1.01
Enterprise Value to EBITDA -0.65
Shares Outstanding 418532000
Shares Floating 400750113
Shares Outstanding 418532000
Shares Floating 400750113
Percent Insiders 5.09
Percent Institutions 22.38

Upturn AI SWOT

Clover Health Investments Corp. (CLOV) - A Comprehensive Overview

Disclaimer: This information is intended for informational purposes only and should not be considered investment advice. Please consult a professional financial advisor before making any investment decisions.

Company Profile:

History and Background: Clover Health is a relatively young company, founded in 2013. The company initially focused on providing Medicare Advantage plans to seniors in the United States. However, in 2021, Clover Health went public through a Special Purpose Acquisition Company (SPAC) merger with Social Capital Hedosophia Holdings Corp. The company's stock is currently traded on the Nasdaq exchange under the ticker symbol CLOV.

Core Business Areas: Clover Health operates in two primary business areas:

  • Medicare Advantage Plans: Clover Health offers a variety of Medicare Advantage plans to seniors in the United States. These plans provide comprehensive healthcare coverage, including hospitalization, doctor visits, and prescription drugs.
  • Clover Assistant: Clover Assistant is a software platform that uses artificial intelligence (AI) to help manage the healthcare needs of Clover Health's members. Clover Assistant can help members schedule appointments, track their health information, and receive personalized recommendations.

Leadership Team and Corporate Structure: Clover Health's leadership team consists of experienced individuals with a strong track record in the healthcare industry. The company's CEO is Vivek Garipalli, who previously founded and sold a healthcare technology company.

Top Products and Market Share:

Top Products:

  • Clover Assistant - AI-powered health management platform
  • Clover Health Medicare Advantage plans

Market Share:

  • Clover Health currently holds a small market share in the Medicare Advantage market. However, the company is growing rapidly and expects to increase its market share in the coming years.

Comparison with Competitors: Clover Health's primary competitors include:

  • Humana (HUM)
  • Centene (CNC)
  • UnitedHealth Group (UNH)

Clover Health differentiates itself from its competitors by offering a more personalized and technology-driven approach to healthcare.

Total Addressable Market: The total addressable market for Medicare Advantage plans in the United States is approximately 28 million people. This market is expected to grow significantly in the coming years as the population ages.

Financial Performance:

Recent Financial Statements: Clover Health is a relatively young company and has yet to achieve profitability. However, the company is growing rapidly and is expected to reach profitability in the near future.

Year-over-Year Comparison: Clover Health's revenue has grown significantly in recent years. However, the company is still reporting net losses.

Cash Flow and Balance Sheet: Clover Health's cash flow and balance sheet are relatively healthy. The company has a strong cash position and low levels of debt.

Dividends and Shareholder Returns: Clover Health does not currently pay dividends. The company's shareholder returns have been mixed since its IPO.

Growth Trajectory:

Historical Growth: Clover Health has experienced significant revenue growth in recent years. The company's membership base has also grown rapidly.

Future Growth: Clover Health is expected to continue to grow rapidly in the coming years. The company is expanding its Medicare Advantage plan offerings and investing heavily in its Clover Assistant platform.

Growth Initiatives:

  • Expansion of Medicare Advantage plan offerings
  • Investment in Clover Assistant platform
  • Partnerships with other healthcare providers

Market Dynamics:

Industry Overview: The Medicare Advantage market is growing rapidly as the population ages. The market is also becoming increasingly competitive as more healthcare providers enter the space.

Clover Health's Position: Clover Health is well-positioned to benefit from the growth of the Medicare Advantage market. The company's technology-driven approach to healthcare is attractive to seniors, and Clover Health is expanding its plan offerings to meet the needs of a diverse population.

Competitors:

Key Competitors:

  • Humana (HUM)
  • Centene (CNC)
  • UnitedHealth Group (UNH)

Competitive Advantages:

  • Technology-driven approach to healthcare
  • Personalized member experience
  • Rapid growth

Competitive Disadvantages:

  • Small market share
  • Lack of profitability
  • High competition

Potential Challenges and Opportunities:

Challenges:

  • Competition from larger healthcare providers
  • Maintaining profitability
  • Managing regulatory changes

Opportunities:

  • Growth of the Medicare Advantage market
  • Expansion into new markets
  • Partnerships with other healthcare providers

Recent Acquisitions (last 3 years):

Clover Health has not made any significant acquisitions in the past 3 years.

AI-Based Fundamental Rating:

Rating: 5/10

Justification: Clover Health is a growing company with a promising future. However, the company is still relatively young and has yet to achieve profitability. The company also faces significant competition from larger healthcare providers.

Sources:

  • Clover Health Investor Relations website
  • Yahoo Finance
  • Seeking Alpha

Further Research & Disclaimer: This overview is not exhaustive and should not be considered investment advice. Please conduct your own research and consult with a financial professional before making any investment decisions.

About Clover Health Investments Corp

Exchange NASDAQ
Headquaters Franklin, TN, United States
IPO Launch date 2001-01-02
Co-Founder, CEO & Director Mr. Andrew Toy
Sector Healthcare
Industry Healthcare Plans
Full time employees 570
Full time employees 570

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​